.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Daiichi Sankyo
McKesson
Novartis
US Army
QuintilesIMS
Dow
Johnson and Johnson
Fish and Richardson

Generated: December 14, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: felbamate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Amneal PharmsFELBAMATEfelbamateSUSPENSION;ORAL202385ANDAAmneal Pharmaceuticals LLC65162-686-90473 mL in 1 BOTTLE (65162-686-90)
Amneal PharmsFELBAMATEfelbamateSUSPENSION;ORAL202385ANDAAmneal Pharmaceuticals LLC65162-686-88237 mL in 1 BOTTLE (65162-686-88)
Taro PharmFELBAMATEfelbamateSUSPENSION;ORAL206314ANDATaro Pharmaceuticals U.S.A., Inc.51672-4172-1237 mL in 1 BOTTLE (51672-4172-1)
Taro PharmFELBAMATEfelbamateSUSPENSION;ORAL206314ANDATaro Pharmaceuticals U.S.A., Inc.51672-4172-9473 mL in 1 BOTTLE (51672-4172-9)
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189NDAMeda Pharmaceuticals Inc.0037-0430-01100 TABLET in 1 BOTTLE, PLASTIC (0037-0430-01)
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189NDAMeda Pharmaceuticals Inc.0037-0431-01100 TABLET in 1 BOTTLE, PLASTIC (0037-0431-01)
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189NDAMeda Pharmaceuticals Inc.0037-0442-67237 mL in 1 BOTTLE, PLASTIC (0037-0442-67)
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189NDAMeda Pharmaceuticals Inc.0037-0442-17946 mL in 1 BOTTLE, PLASTIC (0037-0442-17)
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189NDA AUTHORIZED GENERICWallace Pharmaceuticals Inc.51525-0430-1100 TABLET in 1 BOTTLE (51525-0430-1)
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189NDA AUTHORIZED GENERICWallace Pharmaceuticals Inc.51525-0431-1100 TABLET in 1 BOTTLE (51525-0431-1)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
Deloitte
Cantor Fitzgerald
Farmers Insurance
Johnson and Johnson
Moodys
McKinsey
Queensland Health
Fuji

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot